Donaldson Company stock overview

Donaldson Company (DCI) has drawn investor attention after a mixed stretch for the share price, with a negative move over the past 3 months contrasting with a positive total return over the past year.

At a recent close of $86.22, the filtration specialist and its segments across Mobile Solutions, Industrial Solutions, and Life Sciences are set against a backdrop of single digit annual revenue growth and double digit annual net income growth.

The recent 1 day share price return of a 2.21% decline and 7 day share price return of a 3.08% decline sit against a 1 year total shareholder return of 30.03%, so recent momentum has softened even as longer term holders have seen gains.

If you are comparing Donaldson with other industrial names tied to infrastructure and energy trends, it can be useful to see what else is on the move through the 35 power grid technology and infrastructure stocks

With Donaldson trading at $86.22, a 7% discount to one estimate of intrinsic value and roughly 12% below the average analyst target of $96.40, you have to ask whether there is still a buying opportunity here or if the market is already pricing in future growth.

Most Popular Narrative: 10.6% Undervalued

With Donaldson Company trading at $86.22 against a narrative fair value of $96.40, the most followed view sees upside that the current price does not fully reflect yet.

Global expansion of environmental regulations and emissions standards is increasing demand for advanced filtration across industrial and transportation sectors, positioning Donaldson to achieve record sales in both Industrial Solutions and Mobile Solutions, with a direct positive impact on revenue and earnings growth in FY26 and beyond. Industrial automation and digitalization are driving higher requirements for contaminant-free environments, fueling double-digit growth in Donaldson's connected and aftermarket filtration solutions, improving the recurring revenue base and operating margins.

Curious what assumptions sit under that fair value gap? Revenue stepping higher, margins rebuilding, and a future earnings multiple that has to align neatly with those forecasts.

Result: Fair Value of $96.40 (UNDERVALUED)

However, there are still pressure points, including potential bioprocessing delays in Life Sciences and sensitivity to tariffs and input costs that could squeeze margins.

Next Steps

If that blend of optimism and caution leaves you curious, move quickly to check the numbers yourself and then weigh up the 2 key rewards

Looking for more investment ideas?

If Donaldson has your attention, do not stop here. Broaden your watchlist with other stocks that fit different goals so you are not missing fresh opportunities.

• Target resilient cash generators by scanning companies in the solid balance sheet and fundamentals stocks screener (44 results).
• Hunt for potential mispriced opportunities by reviewing the 50 high quality undervalued stocks.
• Prioritize income and stability by focusing on companies highlighted in the 13 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.